Rocchetti et al. showed that anti-VEGF drugs have a potential benefit in bladder tumors that express VEGF.[27] However, anti-VEGF drugs in bladder tumor therapy are considered investigational yet. Here, VEGFA is linked to urinary bladder neoplasm.